Pharmacogenomics of warfarin in populations of African descent.
Ontology highlight
ABSTRACT: Warfarin is the most commonly prescribed oral anticoagulant worldwide despite its narrow therapeutic index and the notorious inter- and intra-individual variability in dose required for the target clinical effect. Pharmacogenetic polymorphisms are major determinants of warfarin pharmacokinetic and dynamics and included in several warfarin dosing algorithms. This review focuses on warfarin pharmacogenomics in sub-Saharan peoples, African Americans and admixed Brazilians. These 'Black' populations differ in several aspects, notably their extent of recent admixture with Europeans, a factor which impacts on the frequency distribution of pharmacogenomic polymorphisms relevant to warfarin dose requirement for the target clinical effect. Whereas a small number of polymorphisms in VKORC1 (3673G >
SUBMITTER: Suarez-Kurtz G
PROVIDER: S-EPMC3579249 | biostudies-literature | 2013 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA